Merck’s new cholesterol drug Enlicitide has shown strong results in late-stage clinical trials.
Pharmaceutical giant Merck & Co. announced a promising development in the treatment of high cholesterol. In a statement on Monday, the company said its new cholesterol-lowering candidate, enlicitide decanoate, successfully reached its
